Skin and Soft Tissue Infections (SSTI) Antibiotic Guidelines (Adult) Contents. Section
|
|
- May Wells
- 5 years ago
- Views:
Transcription
1 Antibiotic Guidelines (Adult) Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique ID: 144TD(C)25(B3) Issue number: 5 Expiry Date: June 2019 Contents Section Who should read this document Key practice points Background What is new in this version Policy/Procedure/Guideline Clinical assessment Microbiological Investigations: Empiric treatment of SSTI MRSA Infections Other considerations in SSTI Management of cellulitis at home with intravenous antibiotics Post-operative wound Infections Prophylaxis and Treatment of Mammalian Bites Antibiotic Prophylaxis for wounds in the Emergency department Treatment of Septic Bursitis Peritoneal dialysis catheter-associated exit site infection Standards References and Supporting Documents Roles and responsibilities Document control information (Published as separate document) Document Control Policy Implementation Plan Monitoring and Review Endorsement Equality analysis Page 1 of 16
2 Who should read this document? This policy applies to all clinical staff involved in the prescribing of antimicrobials. Key Practice Points Clinical assessment of the severity of infection is crucial. Microbiological investigations should be undertaken as recommended below. This policy recommends empiric treatment options for adult patients with a skin and soft tissue infection including, Necrotizing fasciitis, Suspected severe PVLassociated S. aureus infection, a mammalian bite, post-operative wound infection and septic bursitis. For treatment of Diabetic Foot Infections please see the Antibiotic Guidelines Diabetic Foot Infections. Identification and management of underlying causes and risk factors for a SSTI is essential. Background Antimicrobial agents are among the most commonly prescribed drugs and account for 20% of the hospital pharmacy budget. Unfortunately, the benefits of antibiotics to individual patients are compromised by the development of bacterial drug resistance. Resistance is a natural and inevitable result of exposing bacteria to antimicrobials. Good antimicrobial prescribing will help to reduce the rate at which antibiotic resistance emerges and spreads. It will also minimise the many side effects associated with antibiotic prescribing, such as Clostridium difficile infection. It should be borne in mind that antibiotics are not needed for simple coughs and colds. In some clinical situations where infection is one of several possibilities, provided the patient is not showing signs of systemic sepsis, a wait and see approach to antibiotic prescribing is often justified while relevant cultures are performed. This document provides treatment guidelines for the most common situations in which antibiotic treatment is required. The products and regimens listed here have been selected by the Trust's Medicines Management Group on the basis of published evidence. Doses assume a weight of 60-80kg with normal renal and hepatic function. Adjustments may be needed for the treatment of some patients. This document provides treatment guidelines for the appropriate use of antibiotics. The recommendations that follow are for empirical therapy and do not cover all clinical circumstances. Alternative antimicrobial therapy may be needed in up to 20% of cases. Alternative recommendations will be made by Page 2 of 16
3 the microbiologist in consultation with the clinical team. This document refers to the treatment of adult patients (unless otherwise stated). What is new in this version? Addition of a new section on the use of antibiotic prophylaxis for wounds in the Emergency Department References updated Policy/ Guideline/ Protocol Microbiology of SSTI The most common infecting organisms causing skin & soft tissue infection (SSTI) are (in decreasing order of frequency): Staphylococcus aureus, other Gram positive cocci, Gram negative bacilli and anaerobes. If the causative organism(s) is (are) identified, therapy may be modified after discussion with a microbiologist. A number of different bacteria can cause necrotising fasciitis. Where a single agent is involved, this is typically a community-acquired Group A streptococcus (S. pyogenes). Polymicrobial necrotising infection typically has a mixture of anaerobic and aerobic bacteria and may follow penetrating abdominal trauma, be associated with IV drug use or arise from a perianal or Bartholin s abscess. Clinical assessment Assessment must be made to classify the severity of infection as a useful guide to admission and treatment decisions. The system below has been adapted from the CREST guidelines, The treatment of Diabetic Foot Infections is covered in a separate policy, Antibiotic Guidelines- Diabetic Foot Infections. Patient should also be assessed for risk factors for specific pathogens such as: Animal or human bite Exposure to sea or fresh water (discuss treatment options with microbiology) In addition, it is important to recognize features suggesting either necrotizing fasciitis or PVL-associated Staphylococcal infection. Page 3 of 16
4 Microbiological Investigations: Microbiological sampling not routinely required for Class I infections unless recent antimicrobial therapy or previous antibiotic-resistant organisms. Cultures should be taken from any skin break/ulceration or blister fluid for Class II, III and IV infections. Blood Cultures should be taken for any Class III or IV infections Recommendations for Sample collection Collect swab specimens before antimicrobial therapy where possible. Specimens should be transported and processed as soon as possible. The volume of the specimen influences the transport time that is acceptable. Large volumes of purulent material maintain the viability of anaerobes for longer. The recovery of anaerobes is compromised if the transport time exceeds 3 hr. If processing is delayed, refrigeration is preferable to storage at ambient temperature. Delays of over 48hr are undesirable for best result outcome Pus swabs; Pus when present, is preferable to a swab, particularly from deep seated infection sites. Ideally, a minimum volume of 1mL of pus should be sent. However, pus swabs are acceptable when pus is not readily available or if the area to be sampled is superficial. When using swabs, please sample the deepest part of the wound, or a representative part of the lesion. Swabbing dry crusted areas is unlikely to yield the causative pathogen. Ulcers: If specimens are taken from ulcers, the debris on the ulcer should be removed and the ulcer should be cleaned with saline. A biopsy or, preferably, a needle aspiration of the edge of the wound should then be taken. A less invasive irrigation-aspiration method may be preferred. Place the tip of a small needleless syringe under the ulcer margin and irrigate gently with at least 1 ml sterile 0.9% NaCl without preservative. After massaging the ulcer margin, repeat the irrigation with a further 1 ml sterile saline. Massage the ulcer margin again, aspirate approximately 0.25 ml of the fluid and transfer to a sterile container. Swabs should be placed in bacterial transport media. If a delay in transporting to the laboratory is anticipated, please store at 4 o c. Page 4 of 16
5 Empiric treatment of SSTI: Classification First Line Penicillin Allergic MRSA suspected Additional comments Class I: No signs of systemic toxicity No uncontrolled comorbidities Can usually be managed with oral antimicrobials on an outpatient basis Flucloxacillin 1g PO QDS (for patients <80kg 500mg PO QDS may be adequate ) clarithromycin 500mg BD PO doxycycline 100mg BD PO Typical Duration 5 days Class II: Systemically ill or Systemically well but with a co-morbidity such as peripheral vascular disease, chronic venous insufficiency or morbid obesity which may complicate or delay resolution of their infection. Flucloxacillin 1g IV QDS - for patients > 80kg use 2g IV QDS - maximum 1g IV QDS if egfr <15 clarithromycin 500mg IV BD Vancomycin IV Page 5 of 16 A short course of IV therapy is usually necessary. Consider referral for Home IV therapy. See Management of cellulitis at home with intravenous antibiotics below. Continuation treatment as Class I infection, typical duration: 7-14 days. Max. oral dose of flucloxacillin is 1g QDS.
6 Class III: Infection in a patient with evidence of systemic inflammatory response syndrome. Clinically recognised by 2 or more of: Temperature >38.3 o C or <36 o C Heart rate >90/min Resp rate >20/min or PaCO2 <4.3kPa WBC >12,000 or <4000/mm 3 or may have unstable co-morbidities that may interfere with a response to therapy or have a limb threatening infection due to vascular compromise Flucloxacillin 2g IV QDS - maximum 1g IV QDS if egfr <15 If patient is immunocompromised or has had a treatment failure with first line regimes: Piperacillin-tazobactam IV 4.5g TDS Continuation therapy should be based on culture results. If MRSA negative and no positive culture results: coamoxiclav 625mg tds, typical duration 7-14 days. Vancomycin IV If patient is immunocompromised or has had a treatment failure with first line regimes: Add oral ciprofloxacin 500mg BD Continuation therapy should be based on culture results. Vancomycin IV If patient is immunocompromised or has had a treatment failure with first line regimes: Add oral ciprofloxacin 500mg BD Continuation therapy should be based on culture results. Continuation treatment as Class I infection, typical duration: 7-14 days Page 6 of 16
7 Class IV: Severe sepsis (Sepsis plus hypotension {SBP<90 or MAP<70} or signs of organ dysfunction). If refractory hypotension, rash or diarrhoea is present, consider toxic shock syndrome discuss antibiotic treatment with a microbiologist. Necrotising fasciitis: Necrotising fasciitis affects the soft tissue and fascia. Infection usually extends from an area of damaged skin or a surgical wound. Signs may include severe pain which is out of proportion to cutaneous signs wooden-hard feel to subcutaneous tissues subcutaneous extension of Piperacillin-tazobactam IV 4.5g TDS plus Vancomycin IV Vancomycin IV plus clindamycin IV 900mg TDS plus meropenem 1g IV TDS Seek urgent surgical and microbiology advice vancomycin IV plus oral ciprofloxacin 500mg BD plus oral metronidazole 400mg TDS If penicillin allergic with history of anaphylaxis, vancomycin IV plus clindamycin IV 900mg TDS plus ciprofloxacin 400mg IV BD As per first line or penicillin allergic As per first line or penicillin allergic Page 7 of 16 Oral continuation therapy should be based on culture results. If MRSA negative and no positive culture results: co-amoxiclav 625mg tds, typical duration 14 days. Rationalised therapy for Group A Streptococcus infection: benzyl penicillin IV plus clindamycin IV/oral Consider IV immunoglobulin therapy if not responding
8 inflammation > cutaneous dark violet skin discolouration or necrosis cutaneous blistering or bullous lesions Systemic toxicity +/- altered mental state Suspected severe PVL-associated S. aureus infection: Panton-Valentine Leukocidin (PVL)- associated infection should be suspected if a patient has a necrotising SSTI, recurrent furunculosis or abscesses, or there is clustering of SSTIs within a household or social group Linezolid (only on Microbiology approval) IV or oral 600 mg BD plus clindamycin 900mg IV TDS Add oral rifampicin 600mg BD in extreme cases or if not responding to therapy As per first line As per first line Flucloxacillin or Clindamycin alone are adequate for moderate SSTI due to PVL MSSA Page 8 of 16
9 MRSA Infections: For microbiologically confirmed MRSA infection, treat according to reported susceptibility test results with one of the following regimens a) vancomycin IV (where infection is severe) b) Daptomycin IV (Microbiology approval required) c) linezolid IV or oral for severe cellulitis where vancomycin is contraindicated (Microbiology approval required) d) clindamycin IV or oral (where MRSA is susceptible to erythromycin) e) doxycycline in mild/moderate infection (where MRSA is susceptible to tetracycline) Other considerations in SSTI: The differential diagnosis of cellulitis includes venous thrombosis and varicose eczema (for which antibiotics are not indicated). Superficial swabs are easily contaminated by colonising bacteria, which may include both skin and faecal organisms. They are poorly predictive of the pathogenic organisms causing the underlying infection. Swab results should therefore be interpreted with caution. Good skin and wound care is important in promoting healing of skin and infected wounds. Emollients, topical antiseptics and specialist dressings may be indicated. Take advice from senior nursing staff, tissue viability specialists and podiatrists, where appropriate. Consider underlying risk factors (such as diabetes, immune deficiency, leg ulcers, lymphoedema, leg oedema, venous insufficiency, and obesity) and manage these appropriately. Diabetic patients with foot ulcers must be referred to the Podiatry service. Consider the possibility of underlying osteomyelitis: investigate and treat appropriately. Consider whether a soft tissue collection is present and needs incision and drainage. Bacterial soft tissue infection may arise secondary to fungal nail or interdigital skin infections: investigate and treat if indicated. Page 9 of 16
10 Management of cellulitis at home with intravenous antibiotics: Patients admitted via the Emergency department or the Emergency Assessment Unit (EAU) with cellulitis may be considered for Home/Outpatient IV Therapy (HOPT). This part of the service is provided by the Rapid Response Team ( ). The criteria for this service are outlined below. Please contact Rapid Response team for full details. INCLUSION CRITERIA EXCLUSION CRITERIA Cellulitis with associated lymphangitis +/- lymphadenopathy Cellulitis which has not improved with oral antibiotics or cellulitis with pyrexia Salford resident or Salford GP At least 18 years of age Access to a telephone Suitable home environment Any other acute medical problem requiring admission Evidence of severe sepsis (e.g. hypotension, new onset confusion) Cellulitis associated with suspected underlying bone or joint involvement Facial or ophthalmic cellulitis Breast cellulitis Significant mental health or substance misuse issues Post-operative wound Infections A surgical wound infection is likely to be present if two out of the following are present, Temperature above 38 0 C Pus at the operative site Spreading cellulitis around the wound. Antibiotic management as per Empiric treatment of SSTI above unless the wound is likely to be contaminated by faecal flora e.g. perianal wound or stoma site infection in which case use co-amoxiclav IV/oral in place of flucloxacillin. Prophylaxis and treatment of Mammalian bites: Mammalian bites are typically colonised by pathogens found in the oral cavities of the offending animal. These are a mixture of aerobic and anaerobic micro-organisms including; Streptococci, Staphylococci, Moraxella, Neisseria. Fusobacterium, Bacteroides, Porphyromonas, and Prevotella spp. Pasteurella multocida is a Gram-negative pathogen particularly prevalent in dog (57%) and cat (75%) bites. In cases of human bite wounds and clenched fist wounds, where HIV and Hepatitis B status is unknown, please treat patients in line with the Trust s PEP policy. Page 10 of 16
11 Prophylaxis of mammalian bites is indicated in the following circumstances; All cat bites, animal bites to the hand, foot and face; puncture wounds; wounds requiring surgical debridement; wounds involving joints, tendons, ligaments or suspected fracture Clenched-fist wounds (wound inflicted from a punch coming in contact with teeth) Wounds that have undergone primary closure People who are at risk of serious wound infection e.g. diabetic, cirrhotic, asplenic or immunocompromised patients People with a prosthetic valve or prosthetic joint NB: All patients with mammalian bites (especially dog bites) inflicted outside of the UK and Ireland should be considered for rabies vaccination, as should bites inflicted by bats from within UK and Irish borders. Prophylaxis of infection: Co-amoxiclav 625mg tds for 5 days. If penicillin allergic; Doxycycline 100mg bd PO and metronidazole 400mg tds PO for 5 days. Antibiotics are not usually required in newly presenting patients if the wound is greater than two days old and there is no sign of infection. Treatment of infection (wounds >2days old showing signs of infection): Mild inflammation Co-amoxiclav 625mg tds for 7-14 days. If penicillin allergic; Doxycycline 100mg bd PO and metronidazole 400mg tds PO for 7-14 days. Moderate to severe inflammation: Co-amoxiclav 1.2g tds IV Continuation treatment as for mild infection, typical duration: 7-14 days If penicillin allergic; Please consult microbiology for recommendation. Swabs should be taken from newly presenting wounds greater than two days old, that are exhibiting signs of infection, prior to commencing antibiotic therapy to assist with rationalising treatment once cultures and sensitivities are available. Page 11 of 16
12 Antibiotic Prophylaxis for wounds in the Emergency department: All wounds should be irrigated copiously with sterile saline, and grossly visible debris should be removed. Lacerations: For simple lacerations with no current signs of infection, antibiotic prophylaxis is NOT recommended. Proper wound preparation is the essential measure for preventing wound infection after suturing simple lacerations. Advise the patient to seek medical attention if they develop signs of infection. Patients with more complex lacerations that require more than just simple cleaning and who require referral to other specialities may require antibiotic prophylaxis. This should be discussed with the specialists on an individual patient basis. Puncture wounds: Do NOT routinely offer antibiotic prophylaxis for puncture wounds. Offer antibiotic prophylaxis for patients at high risk for subsequent infection: contaminated puncture wounds (especially with organic matter), diabetes mellitus, immunodeficiency, a retained organic foreign body, or injuries through an intact shoe. All patients with puncture wounds should be followed closely for evidence of infection, regardless of whether or not they receive prophylactic antibiotics. Prophylaxis regimes: First line: Flucloxacillin 500mg QDS PO (for patients >80kg use 1g QDS PO) Penicillin allergy: Clarithromycin 500mg BD for 3 days Contamination with organic matter e.g. soil: Co-amoxiclav 625mg TDS Duration of Prophylaxis: Antibiotic prophylaxis should not be prescribed for longer than 72 hours. Tetanus immunisation: Check the patient s tetanus immunization status and administer a booster dose of tetanus vaccine if needed. Page 12 of 16
13 Treatment of Septic Bursitis: Treatment of septic bursitis requires appropriate antibiotics, optimally guided by identification of the organism and antibiotic sensitivity testing. Draining of the infected bursa fluid is also indicated in the management of infected bursae. Initial antibiotic selection is guided by knowledge of common pathogens. In 80% of cases this is Staphylococcus aureus or other Grampositive organisms. Rationalisation of therapy should be conducted if cultures and sensitivities indicate an atypical pathogen. Treatment choice: Mild inflammation: Flucloxacillin 500mg qds PO (for patients >80kg use 1g qds PO) If penicillin allergic, clarithromycin 500mg bd PO If MRSA is suspected: doxycycline 100mg bd PO Typical duration: 14 days Moderate/Severe inflammation: Flucloxacillin 1g qds IV (for patients >80kg use 2g qds IV) If penicillin allergic or MRSA is suspected: Vancomycin IV. Treatment of Peritoneal Dialysis Exit Site Infections: Purulent drainage from the catheter exit site indicates the presence of infection. Erythema may or may not represent infection. An exit site infection is defined by the presence of purulent drainage, with or without erythema of the skin at the catheter-epidermal interface. Pericatheter erythema without purulent drainage is sometimes an early indication of an infection. In recently inserted catheters or following trauma, erythema may represent a skin reaction. Clinical judgement must be exercised to decide where antibiotic therapy should be commenced. Note, a positive culture on routine screening indicates colonisation rather than infection. Eradication of MSSA or MRSA using mupirocin nasal ointment in combination with enhanced exit site antiseptic cleaning is required. Patients presenting with discharge from the exit site and possible exit site infection should have the exit site swabbed and sent to microbiology for culture and sensitivity. Sensitivities should be reported in hours. Most exit site infections are due to Gram positive (e.g. S. aureus) bacteria. Gram negative infections (e.g. P. aeruginosa, E. coli) are less common. Tunnel infections usually present as erythema, oedema or intense tenderness over the subcutaneous pathway. In the majority of cases this will be concurrent with an exit site infection. Staphylococcus aureus and Pseudomonas aeruginosa exit site infections in particular are often associated with tunnel infections. Page 13 of 16
14 Initial treatment should be given to cover Staphylococcus aureus: [If the patient has a history of Pseudomonas aeruginosa infections therapy should be given to cover this pathogen in addition]. Flucloxacillin 500mg qds PO (for patients >80kg use 1g qds PO) If penicillin allergic, clarithromycin 500mg bd PO Treatment should be reviewed weekly and continued for days (until signs of infection have resolved and the exit site appears normal) Patients with signs of systemic illness (SIRS criteria present) and patients with cellulitis extending more than 2cm from the catheter exit site will require individualisation of antibiotic therapy and should be discussed with a senior renal physician and a microbiologist. Antimicrobial therapy must be reviewed when cultures & sensitivity results are available: Add rifampicin 300mg bd if rifampicin-susceptible S. aureus is isolated. Pseudomonas aeruginosa infections are especially difficult to treat and may require prolonged therapy with 2 antibiotics following discussion with a microbiologist. First line treatment is ciprofloxacin mg bd for 21 days. Ciprofloxacin should be given at 10am and 10pm to avoid concomitant administration with phosphate binders. Ciprofloxacin doses should be separated from binders by a minimum of 2 hours. For resistant organisms or non-responding infections, seek advice from a consultant nephrologist and a microbiologist: Consideration may need to be given to IV antimicrobial therapy Removal of PD catheter Antibiotic therapy should be continued until the exit site appears entirely normal minimum of two weeks for S. aureus and three weeks for P. aeruginosa. Early catheter removal and replacement should be considered for P.aeruginosa or tunnel infections. Renal Community Team The renal community team must be informed of all patients with exit site infections on diagnosis. Follow up will be determined by the patient s location. Page 14 of 16
15 Standards Indication should be documented. The rationale for any deviation from the Trust s Antibiotic Policy should be documented in a separate clinical note. Review the patient s allergy status prior to prescribing antibiotics. The initial prescription for antibiotics should have the total intended course length from the outset. Prescriptions for IV antibiotics should have be reviewed every 24hrs for suitability to switch to oral antibiotics Relevant culture results should be used to guide treatment where applicable. Patients should be reviewed for VSL#3 sachets in line with Trust policy. Explanation of terms & Definitions N/A References and Supporting Documents Li Philip Kam-Tao et al Peritoneal Dialysis-Related Infections Recommendations: 2010 Update Peritoneal Dialysis International 2010 vol 30 pp Clinical Resource Efficiency Support Team Guidelines on the Management of Cellulitis in adults. Belfast: CREST Infectious Disease Society of America Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections. Clinical Infectious Diseases; 41: Medeiros IM, Saconato H. Antibiotic prophylaxis for mammalian bites. Cochrane Database of Systematic Reviews, 2001; Issue 2. Art. No.: CD DOI: / CD Brakenbury PH, Muwanga C. A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites. Arch Emerg Med., 1989; 6(4): 251. Morgan M, Palmer J. Dog bites. BMJ, 2007; 334 (7590): 413. Dennis L. Stevens, Alan L. Bisno, Henry F. Chambers, E. Patchen Dellinger, Ellie J. C. Goldstein, Sherwood L. Gorbach, Jan V. Hirschmann, Sheldon L. Kaplan, Jose G. Montoya, James C. Wade; Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update Page 15 of 16
16 by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59 (2): e10-e52. doi: /cid/ciu296 Daniel J Sexton, Dlinor L Baron.H Soft tissue infections due to dog and cat bites. UpToDate. [online] Available: bites?source=see_link§ionname=prophylaxis&anchor=h8 Chudnofsky CR, Sebastian S. Special wounds. Nail bed, plantar puncture, and cartilage. Emerg Med Clin North Am., 1992; 10(4): Larry M Baddour, Aaron MP Ed: Daniel J Sexton, MD Allyson Bloom, MD Infectious complications of puncture wounds. UpToDate. [Online] Available: e=1~118§ionrank=1&anchor=h #h Fisher MC, Goldsmith JF, Gilligan PH. Sneakers as a source of Pseudomonas aeruginosa in children with osteomyelitis following puncture wounds. J Pediatrics. 1985; 106(4):607. NICE CKS Lacerations July 2015 NICE CKS (online) Available: Roles and responsibilities All clinical staff involved in the prescribing of antimicrobials to adhere to this policy including full documentation on EPMAR as detailed. Page 16 of 16
Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationProtocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CONTROLLED DOCUMENT
CONTROLLED DOCUMENT Protocol for exit-site care and treatment of exit-site infections in peritoneal dialysis CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Guideline Clinical The purpose
More informationWho should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3
Neurosurgical infections (adult only) Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary
More informationTreatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals
Treatment of Surgical Site Infection Meeting Quality Statement 6 Prof Peter Wilson University College London Hospitals TEG Quality Standard 6 Treatment and effective antibiotic prescribing: People with
More informationWho should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3
Antibiotic Prophylaxis in Cranial Neurosurgery Antibiotic Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary
More informationTo guide safe and appropriate selection of antibiotic therapy for Peritoneal Dialysis patients.
Nephrology Directorate Subject: Objective: Prepared by: Aintree Antibiotic Guidelines for Peritoneal Dialysis (PD): Catheter Insertion, and the Diagnosis and Treatment of PD Peritonitis and Exit-Site Infections.
More informationTreatment of peritonitis in patients receiving peritoneal dialysis Antibiotic Guidelines. Contents
Treatment of peritonitis in patients receiving Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Jude Allen (Pharmacist) Additional author(s): Dr David Lewis, Dr Dimitrios Poulikakos,
More informationANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE
ANTIBIOTIC PRESCRIBING POLICY FOR DIABETIC FOOT DISEASE IN SECONDARY CARE Version 1.0 Date ratified June 2009 Review date June 2011 Ratified by Authors Consultation Nottingham Antibiotic Guidelines Committee
More informationPVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust
PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust Neonatal Case History Neonate born at 26 +2 gestation Spontaneous onset of
More informationGUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
Version 3.1 GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS Date ratified June 2008 Updated March 2009 Review date June 2010 Ratified by Authors Consultation Evidence base Changes
More informationDiabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals
Diabetic Foot Infection Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals History of previous amputation [odds ratio (OR)=19.9, P=.01], Peripheral vascular disease (OR=5.5, P=.007)
More informationWho should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 2. Policy/Procedure/Guideline 4
Antibiotic Guidelines Antibiotic Prophylaxis in Urology Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationSURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS
SURGICAL ANTIBIOTIC PROPHYLAXIS GUIDELINES WITHIN ORTHOPAEDIC SURGERY FOR ADULT PATIENTS Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Pneumonia Community Acquired Pneumonia 1) Is it pneumonia? ie new symptoms and signs of
More informationGuidelines for the Empirical Treatment of Sepsis in Adults (excluding Neutropenic Sepsis)
Guidelines for the Empirical Treatment of Sepsis in Adults (excluding Neutropenic Sepsis) Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationIAEM Clinical Guideline 6 Bite Wound Management in Adults and Children Version 1 July 2016
IAEM Clinical Guideline 6 Bite Wound Management in Adults and Children Version 1 July 2016 Authors: Dr Sinead Ni Bhraonain, Dr Jessica Pflipsen, Dr Éanna Mac Suibhne Guideline lead: Dr Termizi Hassan,
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationStanding Orders for the Treatment of Outpatient Peritonitis
Standing Orders for the Treatment of Outpatient Peritonitis 1. Definition of Peritonitis: a. Cloudy effluent. b. WBC > 100 cells/mm3 with >50% polymorphonuclear (PMN) cells with minimum 2 hour dwell. c.
More informationFelipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare
Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare 100% of all wounds will yield growth If you get a negative culture you something is wrong! Pseudomonas while ubiquitous does
More informationS aureus infections: outpatient treatment. Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium
S aureus infections: outpatient treatment Dirk Vogelaers Dept of Infectious Diseases University Hospital Gent Belgium Intern Med J. 2005 Feb;36(2):142-3 Intern Med J. 2005 Feb;36(2):142-3 Treatment of
More informationGASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT
GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT DRAFT AS CURRENTLY OUT FOR CONSULTATION BUT CAN BE UTILISED IN PRESENT FORMAT Name & Title Of Author: Date Revised: Approved by Committee/Group:
More informationCellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018
Cellulitis Assoc Prof Mark Thomas Conference for General Practice Auckland Saturday 28 July 2018 Summary Cellulitis Usual treatment flucloxacillin for 5 days Frequent recurrences consider penicillin 250mg
More informationDRAFT DRAFT. Paediatric Antibiotic Prescribing Guideline. May
Paediatric Antibiotic Prescribing Guideline www.oxfdahsn.g/children Magdalen Centre Nth, 1 Robert Robinson Avenue, Oxfd Science Park, OX4 4GA, United Kingdom t: +44(0) 1865 784944 e: info@oxfdahsn.g Follow
More informationWho should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 2. Policy/Procedure/Guideline 4
Antibiotic Guidelines Antibiotic Prophylaxis in Urology Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationSepticaemia Definitions 1
Septicaemia Definitions 1 Term Definition Bacteraemia Systemic Inflammatory response (SIRS) Sepsis Bacteria that can be cultured from the blood stream The systemic response to a wide range of stresses.
More informationIntro Who should read this document 2 Key practice points 2 Background 2
Antibiotic Guidelines: Obstetric Anti-Infective Prescribing Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Kelly Alexander / Frances Garraghan
More informationWomen s Antimicrobial Guidelines Summary
Women s Antimicrobial Guidelines Summary 1. Introduction and Who Guideline applies to This guideline has been developed to deliver safe and appropriate empirical use of antibiotics for patients at University
More informationGuidelines for the Medical management of Diabetic Foot Infection
Guidelines for the Medical management of Diabetic Foot Infection Introduction and summary points - Foot infections in diabetic patients usually begin with skin ulceration - However, skin wounds with no
More informationReplaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION
Effective Date: 04/13/17 Replaces:04/14/16 Page 1 of 7 POLICY To standardize the clinical management and housing of offenders with skin and soft tissue infections, thereby reducing the transmission and
More informationSymptoms of cellulitis (n=396) %
Cellulitis and lymphoedema Vaughan Keeley May 2012 What is cellulitis? - also called erysipelas, acute inflammatory episodes etc. - bacterial infection of skin + subcutaneous tissues - more common in people
More informationyour hospitals, your health, our priority PARC (Policy Approval and Ratification Committee) STANDARD OPERATING PROCEDURE:
STANDARD OPERATING PROCEDURE: TRUST ANTIBIOTIC TREATMENT SOP SOP NO: TW10/136 SOP 1 VERSION NO: VERSION 6.1 (JANUARY 2013) APPROVING COMMITTEE: INFECTION PREVENTION AND CONTROL COMMITTEE DATE THIS VERSION
More informationGuidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)
Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults) Community Acquired Community Acquired 1) Is it pneumonia? ie new symptoms and signs of a lower respiratory
More informationRole of the nurse in diagnosing infection: The right sample, every time
BROUGHT TO YOU BY Role of the nurse in diagnosing infection: The right sample, every time The module has been written by Shanika Anne-Marie Crusz and Amelia Joseph Authors affiliation: Department of Clinical
More informationAntibiotics Guidelines: Gastrointestinal Infections
Antibiotics Guidelines: Gastrointestinal Infections Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationPneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC
Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC APPROVED BY: Policy and Guidelines Committee TRUST REFERENCE: B9/2009 AWP Ref: AWP61 Date (approved): July 2008 REVIEW
More informationAppropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases
Appropriate Management of Common Pediatric Infections Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases It s all about the microorganism The common pathogens Viruses
More informationamoxycillin/clavulanate vs placebo in the prevention of infection after animal
Archives of Emergency Medicine, 1989, 6, 251-256 A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites P. H. BRAKENBURY & C. MUWANGA Accident
More informationGUIDELINE FOR ANTIMICROBIAL USE IN THE ORTHOPAEDIC AND TRAUMA DEPARTMENT
GUIDELINE FOR ANTIMICROBIAL USE IN THE ORTHOPAEDIC AND TRAUMA DEPARTMENT Written by: Dr Ken. N. Agwuh, Consultant Microbiologist Mr Roger Helm, Consultant Orthopaedic Surgeon Mr T Kumar, Consultant Orthopaedic
More informationNecrotizing Soft Tissue Infections: Emerging Bacterial Resistance
Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance Eileen M. Bulger, MD Professor of Surgery Harborview Medical Center University of Washington Objectives Review definition & diagnostic
More informationScottish Medicines Consortium
Scottish Medicines Consortium daptomycin 350mg powder for concentrate for solution for infusion (Cubicin ) Chiron Corporation Limited No. (248/06) 10 March 2006 The Scottish Medicines Consortium (SMC)
More informationRemember: AIEs are painful: analgesics should be prescribed regularly and p.r.n. palliativedrugs.com November/December newsletter
ACUTE INFLAMMATORY EPISODES IN A LYMPHOEDEMATOUS LIMB Acute inflammatory episodes (AIEs), often called cellulitis, are common in lymphoedema: mild: pain, increased swelling, erythema (well-defined or blotchy)
More informationAntibiotic Abyss. Discussion Points. MRSA Treatment Guidelines
Antibiotic Abyss Fredrick M. Abrahamian, D.O., FACEP, FIDSA Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar, California
More informationGeneral Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship
General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship Facilitator instructions: Read through the facilitator notes and make note of discussion points for each
More informationAntibiotic guidelines for SKIN AND SOFT TISSUE INFECTIONS
CLINICAL USEFUL INFORMATION RECOMMENDATIONS ALTERNATIVE Impetigo erythematous papules vesicles and pustules honey-colored crusts on an erythematous base Gram stain and culture of the pus or exudates from
More informationIntra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018
Intra-Abdominal Infections Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018 Select guidelines Mazuski JE, et al. The Surgical Infection
More informationAuthor s: Clinical Standards Group and Effectiveness Sub-Board
Trust Antibiotic Policy for the Management of Common Infections in Accident and Emergency and Cromer Minor Injuries Unit (Paediatrics) Accident and Emergency, Norfolk and Norwich and For Use in: Cromer
More informationTrust Guideline for the Management of: Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology
Antibiotic Prophylaxis in adults undergoing procedures in Interventional Radiology A Clinical Guideline For use in: By: For: Division responsible for document: Key words: Interventional Radiology Prescribers
More informationNeurosurgery Antibiotic Prophylaxis Guideline
Neurosurgery Antibiotic Prophylaxis Guideline Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version
More informationEmergency Management of Life Threatening Problems
The management of wounds constitutes a significant topic of Emergency Medicine and I will briefly discuss with you first the emergency management of life threatening problems followed by wound assessment
More informationSurgical Site Infections (SSIs)
Surgical Site Infections (SSIs) Postoperative infections presenting at any level Incisional superficial (skin, subcutaneous tissue) Incisional deep (fascial plane and muscles) Organ/space related (anatomic
More informationInfection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be
Gastrointestinal Infections Infection Comments First Line Agents Penicillin Allergy History of multiresistant Campylobacter Antibiotics not recommended. Erythromycin 250mg PO 6 Alternative to first N/A
More informationGynaecological Surgery in Adults Surgical Antibiotic Prophylaxis
Gynaecological Surgery in Adults Surgical Antibiotic Prophylaxis Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date
More informationDiagnosis and Management of Skin and Soft-tissue Infections
Diagnosis and Management of Skin and Soft-tissue Infections Skin and soft tissue infections (SSTIs), are referred as skin and skin structure infections. These infections also represent a group of infections
More informationAcute Pyelonephritis POAC Guideline
Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice
More informationINFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT
INFECTIONS IN CHILDREN-ANTIMICROBIAL MANAGEMENT Name & Title Of Authors: Dr M Milupi, Consultant Microbiologist Dr N Rao,Consultant Paediatrician Dr V Desai Consultant Paediatrician Date Revised: DEC 2015
More informationCopyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at
Malignant Otitis Externa Inflammation and damage at the base of the skull due to an untreated outer ear P. aeruginosa most common organism Yellow-green drainage from the ear Odor Fever Deep inner ear pain
More informationGive the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS
Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical
More informationTreatment of septic peritonitis
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Treatment of septic peritonitis Author : Andrew Linklater Categories : Companion animal, Vets Date : November 2, 2016 Septic
More informationDisclosures. Consider This Case. Objectives. Consequences of Bites. Animal Bites: What to Do and What to Avoid. Animal Bites: Epidemiology
Animal Bites: What to Do and What to Avoid Meg Fisher, MD Medical Director Disclosures I have no disclosures I do not plan to discuss off label uses of drugs Objectives Manage a child who is bitten Discuss
More informationDiagnosis: Presenting signs and Symptoms include:
PERITONITIS TREATMENT PROTOCOL CARI - Caring for Australasians with Renal Impairment - CARI Guidelines complete list ISPD Guidelines: http://www.ispd.org/lang-en/treatmentguidelines/guidelines Objective
More informationPerichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV
Empiric Antibiotics for Pediatric Infections Seen in ED NOTE: Choice of empiric antibiotic therapy must take into account local pathogen frequency and resistance patterns, individual patient characteristics,
More informationReferences and supporting documents 5 Roles and responsibilities 5
Antibiotic Therapy for Patients with Antibody Deficiency Guidelines for Classification: guidelines Lead Author: Dr Archana Herwadkar, Paul Chadwick Additional author(s): Dr Hana Alachkar Authors Division:
More informationFull Title of Guideline. Author: Contact Name and Job Title. Division & Speciality. Review date December 2020
Full Title of Guideline Author: Contact Name and Job Title Division & Speciality Guideline for the treatment of prosthetic joint infections in adults Mr Peter James - Consultant Orthopaedic Surgeon Dr
More informationMeropenem for all? Midge Asogan ICU Fellow (also ID AT)
Meropenem for all? Midge Asogan ICU Fellow (also ID AT) Infections Common reason for presentation to ICU Community acquired - vs nosocomial - new infection acquired within hospital environment Treatment
More informationAntibiotic Prophylaxis in Adult Orthopaedic Surgery. Formulary/prescribing guideline
Document type: Antibiotic Prophylaxis in Adult Orthopaedic Surgery Version: 2.0 Author (name): Author (designation): Validated by Formulary/prescribing guideline Dr Celia Chu, Dr Katy Edwards, Dr Pradeep
More informationCentral Nervous System Infections
Central Nervous System Infections Meningitis Treatment Bacterial meningitis is a MEDICAL EMERGENCY. ANTIBIOTICS SHOULD BE STARTED AS SOON AS THE POSSIBILITY OF BACTERIAL MENINGITIS BECOMES EVIDENT, IDEALLY
More informationAntimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley
Antimicrobial Update Stewardship in Primary Care Clare Colligan Antimicrobial Pharmacist NHS Forth Valley Setting the Scene! Consequences of Antibiotic Use? Resistance For an individual patient with
More informationThese recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.
Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing
More informationEmpiric antimicrobial use in the treatment of dialysis related infections in RIPAS Hospital
Original Article Brunei Int Med J. 2013; 9 (6): 372-377 Empiric antimicrobial use in the treatment of dialysis related infections in RIPAS Hospital Lah Kheng CHUA, Department of Pharmacy, RIPAS Hospital,
More informationTHERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS
THERAPY OF ANAEROBIC INFECTIONS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu LUNG ABSCESS A lung abscess is a localized pus cavity in
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 3 PURPOSE To assure that DOP inmates with Soft Tissue Infections are receiving high quality Primary Care for their infections and that the risk of infecting other inmates or staff is minimized.
More informationNational Antimicrobial Prescribing Survey
Indication documented Surgical prophylaxis >24 hrs Allergy mismatch Microbiology mismatch Incorrect route Incorrect dose/frequency Incorrect duration Therapeutic Guidelines Local guidelines * Non-compliant
More informationAntibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults
Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults Document type: Prescribing guideline Version: 5.0 Author (name and designation) Samim Patel, Antimicrobial Lead Pharmacist
More informationCELLULITIS / SKIN INFECTIONS
Skin Infections Assessment Investigations Cellulitis Management Abscess Management Infection Control Antibiotic Choice Education Recurrent Infections Referral to Community Nursing References Skin Infections
More informationLe infezioni di cute e tessuti molli
Le infezioni di cute e tessuti molli SCELTE e STRATEGIE TERAPEUTICHE Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Treatment of complicated skin and skin structure infections
More informationRisk factors? Insect bites? Hygiene? Household crowding Health literacy
Recurrent boils Commonest sites face, neck, armpits, shoulders, and buttocks (bottom) infection of the hair root or sweat pore Occur in otherwise healthy people (higher rates in diabetics, eczema, iron
More informationAntibiotic prophylaxis guideline for colorectal, hepatobiliary and vascular surgery for adult patients.
Antibiotic prophylaxis guideline for colorectal, hepatobiliary and vascular surgery for adult patients. Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience,
More informationAntibiotic Prophylaxis Update
Antibiotic Prophylaxis Update Choosing Surgical Antimicrobial Prophylaxis Peri-Procedural Administration Surgical Prophylaxis and AMS at Epworth HealthCare Mr Glenn Valoppi Dr Trisha Peel Dr Joseph Doyle
More informationProphylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi
Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health
More informationNHS Dumfries And Galloway. Surgical Prophylaxis Guidelines
NHS Dumfries And Galloway Surgical Prophylaxis Guidelines The aim of surgical prophylaxis is to reduce rates of surgical site and health-care associated infections and so reduce surgical morbidity and
More informationDuke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients
Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients PURPOSE Fever among neutropenic patients is common and a significant cause of morbidity
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More informationnotification of entry onto webpage Document Links
Document Details Title Co-amoxiclav 250/125 tablets, co-amoxiclav 500/125 tablets, co-amoxiclav 125/31.25 oral suspension and co-amoxiclav 250/62 oral suspension Patient Group Direction (PGD) Trust Ref
More informationAntimicrobial Selection and Therapy for Equine Musculoskeletal Trauma
Antimicrobial Selection and Therapy for Equine Musculoskeletal Trauma Lucio Petrizzi DVM DECVS Università degli Studi di Teramo Surgical site infections (SSI) Microbial contamination unavoidable Infection
More informationSkin & Soft Tissue Infections (SSTIs)
Skin & Soft Tissue Infections (SSTIs) Marnie Peterson, Pharm.D., Ph.D. College of Pharmacy peter377@umn.edu (612) 626-4388 SSTIs Objectives To classify types of skin infections To present a case of cellulitis
More informationTREATMENT OF PERITONEAL DIALYSIS (PD) RELATED PERITONITIS. General Principles
WA HOME DIALYSIS PROGRAM (WAHDIP) GUIDELINES General Principles 1. PD related peritonitis is an EMERGENCY early empiric treatment followed by close review is essential 2. When culture results and sensitivities
More informationRational management of community acquired infections
Rational management of community acquired infections Dr Tanu Singhal MD, MSc Consultant Pediatrics and Infectious Disease Kokilaben Dhirubhai Ambani Hospital, Mumbai Why is rational management needed?
More informationPRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE
PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse
More informationInvasive Group A Streptococcus (GAS)
Invasive Group A Streptococcus (GAS) Cause caused by a bacterium commonly found on the skin and in the throat transmitted by direct, indirect or droplet contact with secretions from the nose, and throat
More informationAntibiotic Prophylaxis in General Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in General Surgery Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Authors Division: CSS&TM Unique ID: 144TD(C)25(F3) Issue number:
More informationHealth PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults
Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults COMMUNITY-ACQUIRED PNEUMONIA HEALTHCARE-ASSOCIATED PNEUMONIA INTRA-ABDOMINAL INFECTION
More informationProvincial Drugs & Therapeutics Committee Memorandum Version 2
Provincial Drugs & Therapeutics Committee Memorandum Version 2 16 Garfield Street 16, rue Garfield PO Box 2000, Charlottetown C.P. 2000, Charlottetown Prince Edward Island Île-du-Prince-Édouard Canada
More informationGuideline for the diagnosis and treatment of PD peritonitis and exit site infections in adults
Full title of guideline Author Division & Speciality Scope (Target audience, state if Trust wide) Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis)
More informationSkin and Soft Tissue Infections Emerging Therapies and 5 things to know
2011 MFMER slide-1 Skin and Soft Tissue Infections Emerging Therapies and 5 things to know Aaron Tande, MD Assistant Professor of Medicine October 27, 2017 Division of INFECTIOUS DISEASES 2011 MFMER slide-2
More informationCLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:
CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationNottingham Renal and Transplant Unit
Nottingham Renal and Transplant Unit Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if Trust wide): Review date (when this version goes out
More informationCLINICAL USE OF BETA-LACTAMS
CLINICAL USE OF BETA-LACTAMS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu WHY IS INFECTIOUS DISEASE PHARMACOTHERAPY SO CONFUSING? Microbial
More informationVolume. December Infection. Notes. length of. cases as 90% 1 week. tonsillitis. First Line. sore throat / daily for 5 days. quinsy >4000.
Volume 8; Number 22 LINCOLNSHIRE GUIDELINES FOR THE TREATMENT OF COMMONLYY OCCURRING INFECTIONS IN PRIMARY CARE: WINTER 2014/15 In this issue of the PACE Bulletin we present an update of our Guidelines
More information